HSV and the CNS

Neuroscientist

Volumn 2, Issue 1, 1996, Pages 44-54

  Meyding Lamadé, Uta ^a   Lamadé, Wolfram ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clinical; CNS; Experimental; Herpes simplex virus infections

Indexed keywords

EID: 0344312705     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200112     Document Type: Review

References (68)

1. Straus S, Rooney JF, Sever JL, Seilding M, Nusinoff-Lehrman S, Cremer K. Herpes simplex virus infection: biology, treatment and prevention. Ann Intern Med 1985;103:404-419.
2. Whitley RJ, Cobbs CG, Alford CA Jr, et al. Diseases which mimic herpes simplex encephalitis: diagnosis, presentation and outcome. JAMA 1989;262:234-239.
3. Aurelius E, Johansson B, Sköldenberg B, Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by PCR or type specific antibody assays of cerebrospinal fluid. J Med Virol 1993;39:179-192.
4. Adams JH, Short IA. Herpes simplex encephalitis: a clinical and pathological analysis of twenty-two cases. Postgrad Med J 1973;49:393-397.
5. Kristensson K, Wisniewski HM. Arrest of myelination and demyelination in rabbit retina induced by herpes simplex virus infection. Neuropathol Appl Neurobiol 1978;4:25-36.
6. Kristensson K, Svennerholm B, Persson L, Vahlne A, Lycke E. Latent herpes simplex virus trigeminal ganglionic infection in mice and demyelination in the central nervous system. J Neurol Sci 1979;43:253-264.
7. Bishop SA, Hill TJ. Herpes simplex virus infection and damage in the central nervous system: immune response to myelin basic protein. J Neurol Sci 1989;91:109-118.
8. Bishop SA, Hill TJ. Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclophosphamide and cyclosporin A. Arch Virol 1991;116:57-68.
9. Fink JF. HSV-mediated gene transfer. Proc Tutorials Am Acad Neurol 1993;422:1-14.
10. Drobyski W, Knox K, Majewski D, Carrigan D. Fatal encephalitis due to a variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;19:1356-1360.
11. Roizman B. Herpesviridae: a brief introduction. In: Fields BN, Knipe DM, chief editors. Fundamental virology. New York: Raven Press 1991:841-846.
12. Ward PL, Roizman B. Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet 1994;10:267-274.
13. Honess RW, Roizman B. Regulation of herpes viruses macromolecular synthesis: cascade regulation of the synthesis of three groups of proteins. J Virol 1974;14:8-19.
14. Anderson JR, Field HJ. The distribution of herpes simplex virus type 1 antigen in mouse central nervous system affecting different routes of inoculation. J Neurol Sci 1983;69:181-195.
15. McFarland DJ, Sikora E, Hotchin J. The production of focal herpes encephalitis in mice by stereotactic inoculation of virus, anatomical and behavioral effects. J Neurol Sci 1986;72:307-318.
16. Hudson SJ, Dix RD, Streilein JW. Induction of encephalitis in SJL mice by intranasal infection with herpes simplex type 1: a possible model of herpes simplex encephalitis in humans. J Infect Dis 1991;163:720-727.
17. Roizman B, Sears A. Herpes simplex viruses and their replication. In: Fields BN, Knipe DM, chief editors. Fundamental virology. New York: Raven Press 1991;850-882.
18. Meyding-Lamadé U, Lamadé W, Heß T, Sartor K, Darai G, Hacke W. Neurovirulence in experimental herpes simplex virus encephalitis: in vivo detection of different strains of HSV. Neurology 1993;43:290-291.
19. Valyi-Nagy T, Deshmane SL, Spivack JG, et al. Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by a HSV-1 mutant, in 1814, that does not replicate in mouse trigeminal ganglia. J Gen Virol 1991;72:641-649.
20. Sears AE, Roizman B. Amplification by host cell factors of a sequence contained within the herpes simplex virus 1 genome. Proc Natl Acad Sci U S A 1990;87:9441-9444.
21. Claoué CMP, Hodges TJ, Darville JM, Hill TJ, Blyth WA, Easty DL. Possible latent infection with herpes virus in the mouse eye. J Gen Virol 1990;71:2385-2390.
22. Steiner I, Spivaek JG, Lirette RP, et al. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J 1989;8:505-511.
23. Hill JM, Sedarati F, Javier RT, Wagner EK, Stevens JG. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 1990;174:117-125.
24. Dobson AT, Sedarati F, Devi-Rao GB, et al. Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J Virol 1989;63:3844-3851.
25. Gordon YI, Johnson B, Romanowski E, Araullo-Cruz T. RNA complementary to herpes simplex virus type 1 ICPO gene demonstrated in neurons of human trigeminal ganglia. J Virol 1988;62:1832-1835.
26. Farrell MJ, Dobson AT, Feldman LT. Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A 1991;88:790-794.
27. Kit S, Dubbs DR. Acquisition of thymidine kinase activity by herpes simplex infected mouse fibriblast cells. Biochem Biophys Res Commun 1963;11:55-59.
28. McDougall JK, Masse TH, Galloway DA. Location and cloning of the herpes simplex virus type 2 thymidine kinase gene. J Virol 1980;33:1221-1224.
29. Kit S. Thymidine kinase. Microbiol Sci 1985;2:369-375.
30. Coen DM, Fleming HE, Leslie LK, Retondo MJ. Sensitivity of arabinosyladenine resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J Virol 1985;53:477-488.
31. Field HJ, Lay E. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir. Antiviral Res 1984;4:43-52.
32. Ellis MN, Waters R, Hill EL, Lobe DC, Selleseth DW, Barry DW. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrob Agents Chemother 1989;33:304-310.
33. Johnson RT. The pathogenesis of herpes simplex virus encephalitis. I. Virus pathways to the nervous system of suckling mice demonstrated by fluorescent antibody staining. J Exp Med 1964;119:343-356.
34. Davis LE, Johnson RT. An explanation for the localization of herpes simplex encephalitis? Ann Neurol 1979;5:2-5.
35. Bastian FO, Rabson AS, Yee CL, et al. Herpes virus hominis: isolation from human trigeminal ganglion. Science 1972;178: 306-307.
36. Baringer JR. Herpes simplex virus infection of the nervous tissue in animals and man. Prog Med Virol 1975;20:1-26.
37. Baringer JR, Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med 1973;288:648-650.
38. Tenser RB, Dunstan ME. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. Virology 1979;99:417-422.
39. Becker Y, Shtram Y, Hadar J, et al. Herpes simplex virus type 1 thymidine kinase (tk) gene controls virus pathogenesis and latency in the nervous system. In: Kohn A, Fuchs P, editors. Mechanisms of viral pathogenesis: from gene to pathogen. Developments in molecular virology. The Hague: Nijihoff 1984, 3rd ed, 293-308.
40. Ben-Hur T, Hadar J, Shtram Y, Gilden DH, Becker Y. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Arch Virol 1983;78:303-308.
41. Field HJ, Coen DM. Pathogenicity of herpes simplex mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol 1986;60:286-289.
42. Cameron JM, McDougall I, Marsden HS, et al. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol 1988;69:2607-2612.
43. Ben-Hur T, Asher Y, Tabor E, Darai G, Becker Y. HSV-1 virulence for mice by the intracerebral route is encoded by the BamH1-L fragment containing the cell fusion gene. Arch Virol 1987;96:117-122.
44. Chou J, Kern ER, Whitley RJ, Roizman B. Mapping of herpes simplex virus-1 neurovirulence to gamma 34,5, a gene nonessenlial for growth in culture. Science 1990;250:1262-1266.
45. Sears AE, Halliburton IW, Meignier B, Silver S, Roizman B. Herpes simplex virus 1 mutant deleted in the a22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J Virol 1985;55:338-346.
46. Sunstream JC, Chrisp CE, Levine M, Glorioso JC. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system. Virus Res 1989;11:17-32.
47. Sköldenberg B. Herpes simplex encephalitis. Scand J Infect Dis Suppl 1991;78:40-46.
48. Whitley R, Schlitt M. Encephalitis caused by herpesviruses, including B virus. In: Schield WM, Whitley RJ, Durack DT editors. Infections of the central nervous system. New York: Raven Press 1991;41-86.
49. Hacke W, Zeumer H. Herpes simplex encephalitis. DMW 1986;111:23-25.
50. Hacke W, Buchner H. Akute Virusencephalitis. In: Hacke W, editor. Neurologische Notfallmedizin. 2nd ed. Düsseldorf: Perimed 1988;124-133.
51. Hindmarsh T, Lindkvist M, Olding-Stenkvist E, Sköldenberg B. Accuracy of computed tomography in the diagnosis of herpes simplex encephalitis. Acta Radiol 1986;209:192-196.
52. Sartor K. Viral infections. In: Sartor K, editor, MR imaging of the skull of the brain. Berlin: Springer 1991;645-648.
53. Tien RD, Felsberg GJ, Osumi AK. Herpesvirus infection of the CNS: MR findings. AJR Am J Roentgenol 1993;161:167-176.
54. Schooley R T. Encephalitis. In: Ropper A, Kennedy S, editors. Neurological and neurosurgical intensive care. 2nd ed. Rockville: Aspen 1988;289-307.
55. Meyding-Lamadé U, Hanley D, Sköldenborg B. Herpesvirus encephalitis. In: Hacke W, editor. Neurocritical care. Berlin: Springer 1994, 455-467.
56. Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA. Herpes simplex encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 1982;145:829-836.
57. Vandvik B, Sköldenberg B, Forsgren M, Stiemstedt G, Jeansson S, Norrby E. Longterm persistence of intrathecal antibody response after herpes simplex encephalitis. J Neurol 1985;231: 307-312.
58. Pohl-Koppe A, Dahm C, Elgas M, Kühn J, Brain R, ter Meulen V. The diagnostic significance of the polymerase chain reaction and isoelectric focusing in herpes simplex virus encephalitis. J Med Virol 1992;36:147-154.
59. Aurelius E, Johansson B, Sköldenberg B, Staland A, Forsgren M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction of cerebrospinal fluid. Lancet 1991;337: 189-192.
60. Baringer JR, Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 1994;36:823-829.
61. Sköldenberg B, Alestig K, Burman L, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: a randomized consecutive study in Swedish patients. Lancet 1984;2:707-711.
62. Birch CJ, Tyssen DP, Tachedijan G, et al. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections. J Infect Dis 1992;166:108-112.
63. Nutter LM, Grill SP, Dutschman GE, Sharma RA, Bobek M, Cheng Y-C. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus. Antimicrob Agents Chemother 1987;31:368-374.
64. Crumpacker CS, Kowalsky PN, Oliver SA, Schnipper LE, Field AK. Resistance of herpes simplex virus to a 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus. Proc Natl Acad Sci U S A 1984;81:1556-1560.
65. Hill EL, Hunter GA, Ellis MN. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1991;35:2322-2328.
66. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991;252:854-856.
67. Freese A, Gellar AI. Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy. Nucleic Acids Res 1991;19:7219-7223.
68. Ezzeddine ZD, Martuza RL, Platika D, et al. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 1991; 3:608-614.